申请人:Merck & Co., Inc.
公开号:US05919776A1
公开(公告)日:1999-07-06
The present invention is directed to aminoquinolines of Formula I: ##STR1## (wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-1, CCR-2, CCR-2A, CCR-2B, CCR-3, CCR-4, CCR-5, CXCR-3, and/or CXCR-4.
本发明涉及公式I的氨基喹啉:##STR1##(其中R.sup.1,R.sup.2,R.sup.3和R.sup.4在此定义),它们可用作趋化因子受体活性的调节剂。特别地,这些化合物可用作趋化因子受体CCR-1、CCR-2、CCR-2A、CCR-2B、CCR-3、CCR-4、CCR-5、CXCR-3和/或CXCR-4的调节剂。